|Original language||English (US)|
|Number of pages||4|
|Journal||Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders|
|Issue number||SUPPL. 1|
|State||Published - Sep 2004|
Bibliographical noteFunding Information:
The Phase III clinical trial of minocycline has been funded by the National Institutes of Health and the Muscular Dystrophy Association and this study is now underway at 31 centers under the direction of Dr. Paul Gordon at Columbia University, New York.